First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug

10.1111/cts.12678

Saved in:

Bibliographic Details
Main Authors:	Teneggi, V, Novotny-Diermayr, V, Lee, LH, Yasin, M, Yeo, P, Ethirajulu, K, Gan, SBH, Blanchard, SE, Nellore, R, Umrani, DN, Gomeni, R, Teck, DLW, Li, G, Lu, QS, Cao, Y, Matter, A
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Published:	Wiley 2021
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/187360
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-187360
record_format	dspace
spelling	sg-nus-scholar.10635-1873602021-10-05T10:02:55Z First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug Teneggi, V Novotny-Diermayr, V Lee, LH Yasin, M Yeo, P Ethirajulu, K Gan, SBH Blanchard, SE Nellore, R Umrani, DN Gomeni, R Teck, DLW Li, G Lu, QS Cao, Y Matter, A DUKE-NUS MEDICAL SCHOOL 10.1111/cts.12678 Clinical and Translational Science 13 1 57-66 2021-03-19T00:41:12Z 2021-03-19T00:41:12Z 2020-01-01 2021-03-18T13:55:00Z Teneggi, V, Novotny-Diermayr, V, Lee, LH, Yasin, M, Yeo, P, Ethirajulu, K, Gan, SBH, Blanchard, SE, Nellore, R, Umrani, DN, Gomeni, R, Teck, DLW, Li, G, Lu, QS, Cao, Y, Matter, A (2020-01-01). First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug. Clinical and Translational Science 13 (1) : 57-66. ScholarBank@NUS Repository. https://doi.org/10.1111/cts.12678 17528054 17528062 https://scholarbank.nus.edu.sg/handle/10635/187360 Wiley Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1111/cts.12678
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Teneggi, V Novotny-Diermayr, V Lee, LH Yasin, M Yeo, P Ethirajulu, K Gan, SBH Blanchard, SE Nellore, R Umrani, DN Gomeni, R Teck, DLW Li, G Lu, QS Cao, Y Matter, A
author	Teneggi, V Novotny-Diermayr, V Lee, LH Yasin, M Yeo, P Ethirajulu, K Gan, SBH Blanchard, SE Nellore, R Umrani, DN Gomeni, R Teck, DLW Li, G Lu, QS Cao, Y Matter, A
spellingShingle	Teneggi, V Novotny-Diermayr, V Lee, LH Yasin, M Yeo, P Ethirajulu, K Gan, SBH Blanchard, SE Nellore, R Umrani, DN Gomeni, R Teck, DLW Li, G Lu, QS Cao, Y Matter, A First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
author_sort	Teneggi, V
title	First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
title_short	First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
title_full	First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
title_fullStr	First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
title_full_unstemmed	First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
title_sort	first-in-human, healthy volunteers integrated protocol of etc-206, an oral mnk 1/2 kinase inhibitor oncology drug
publisher	Wiley
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/187360
_version_	1713213073303535616

First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug

Similar Items